News BiomeSense Raises $2 Million In Seed Round Funding University of Chicago’s Polsky Center for Entrepreneurship and Innovation has provided support for company through funding and programs BiomeSense, a microbiome startup developing a novel biosensor and analytics platform...
Page Venture Gallery Venture Gallery View startups founded from across the University of Chicago ecosystem in a range of industries. Welcome to the Venture Gallery! The Polsky Center provides “first look” and early...
News UChicago Microbiome Startups Come Together Under New Company to Amplify Results Two University of Chicago startups are now operating under a parent company, 32 Biosciences – with a shared goal to revolutionize health care through advances in microbiome science. The name...
News Meet Abigail Prescott, the Polsky Center’s New Executive Director of Marketing and Communications The Polsky Center for Entrepreneurship and Innovation is pleased to announce that Abigail Prescott has joined the executive leadership team as executive director of marketing and communications. She will lead...
News Scientists and Business Leaders Tackle Shared Challenges at First-ever Chicago Microbiome Conference What singular topic has the ability to unite researchers studying skin care, cancer, irritable bowel disease, and Alzheimer’s disease? The microbiome – the study of the bacteria, fungi, and other...
News Innovation Fund Invests $250,000 in Microbiome-based Startup The University of Chicago Innovation Fund has announced plans to invest up to $250,000 into BiomeSense, a startup developing a fully-automated biosensor for low-cost, scalable microbiome testing. On Thursday, May...
News UChicago Microbiome Startup Making Strides in Life Sciences Accelerator IndieBio BiomeSense is spending the next couple of months in San Francisco as part of IndieBio’s current accelerator class.
News UChicago Researchers, Booth Students to Connect at Fall Collaboratorium Seven teams from across the University of Chicago presented at the Collaboratorium, which brings together Chicago Booth students with researchers and faculty who are exploring commercialization opportunities for their work....
News Innovation Fund Invests $500,000 in Microbiome Research and Energy Companies The University of Chicago Innovation Fund announced plans to invest up to $500,000 into three companies—AVNovum, ClostraBio, and SwitchedSource—that are working in the health and energy fields, respectively. These latest...
Technology Diagnostic For Predicting Hospital-Acquired Infections And Identifying Causative Organisms The technology is a fecal microbiome metabolite profile that can predict hospital-acquired infections and identify the causative organisms. This method efficiently measures specific chemical metabolites produced by bacteria in the…
News Polsky Center Fall 2021 I-Corps Teams Tackle Unmet Medical Needs, Data Transparency, and Other Challenges The Polsky Center’s fall 2021 I-Corps cohort is developing diagnostics, novel therapeutics, innovative devices, new materials, and other technologies across various industries. The Polsky I-Corps program is a 7-week highly-experiential...
News CRISPR-Modified Skin Grafts to Treat Addiction? ‘The Opportunities Are Endless,’ Says CEO AddGraft Therapeutics has developed a novel platform that aims to effectively treat substance use disorders with genetically engineered skin grafts – a first-of-its-kind treatment with myriad applications. Developed by University of...
